Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1001996

	registered interest
	date	05/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Reciprocal Arrangements
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent progress has been made on securing healthcare agreements with the EU similar to those set out in EU Regulations (a) 883/2004 and (b) 987/2009.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Tom Brake
	uin	187987
	answer	answer is ministerial correction date of answer 13/11/2018 answer text <p>The Withdrawal Agreement provides that reciprocal healthcare should continue until the end of the Implementation Period (until 31 December 2020) and provides longer-term rights for people covered by the Withdrawal Agreement.</p><p> </p><p>The United Kingdom Government remains focused on securing a broader agreement with the European Union on reciprocal healthcare rights as part of the UK’s future relationship with the EU. It has made clear in the White Paper of July 2018, ‘The Future Relationship Between The United Kingdom and the European Union’, that it is seeking agreement on reciprocal healthcare cover for state pensioners retiring to the EU or the UK, continued participation in the European Health Insurance Card scheme and cooperation on planned medical treatment.</p><p> </p><p>On Friday 26 October, the Government introduced The Healthcare (International Arrangements) Bill which will provide the Government with the powers that are needed to fund and effectively implement arrangements for UK nationals to obtain healthcare abroad after the UK exits the EU.</p> answering member constituency North East Cambridgeshire answering member printed Stephen Barclay question first answered 13/11/2018 11:54:41 answering member 4095 label Biography information for Steve Barclay
	tabling member	151 label Biography information for Tom Brake

1011610

	registered interest
	date	21/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Lumacaftor/ivacaftor
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that cystic fibrosis sufferers have access to Orkambi.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Tom Brake
	uin	194005
	answer	answer is ministerial correction date of answer 29/11/2018 answer text <p>The National Institute for Health and Care Excellence (NICE) and NHS England are in dialogue with Vertex Pharmaceuticals around access to their portfolio of cystic fibrosis medicines. It is critical that Vertex now re-engages fully with the NICE appraisal process and gives serious consideration to the portfolio deal offer that NHS England made at the end of July. This deal would provide immediate access for patients to all Vertex licensed medicines and future pipeline products once licensed and in advance of the individual NICE appraisals concluding.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 29/11/2018 16:56:46 answering member 4067 label Biography information for Steve Brine
	tabling member	151 label Biography information for Tom Brake

1011611

	registered interest
	date	21/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if his Department will introduce a new 5-year survival target of 28 per cent by 2029 for (a) lung, (b) liver, (c) brain, (d) oesophageal, (e) pancreatic and (f) stomach cancer.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Tom Brake
	uin	194006
	answer	answer is ministerial correction date of answer 29/11/2018 answer text <p>The Prime Minister announced ambitions for the National Health Service Long Term Plan that will see 55,000 more people surviving cancer for five years in England each year from 2028 and three quarters of all cancers detected at an early stage by 2028. To achieve these ambitions, we will need to make signification progress on survival across all cancers, including lung, liver, brain, oesophageal, pancreatic and stomach cancers.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 29/11/2018 17:24:18 answering member 4067 label Biography information for Steve Brine
	tabling member	151 label Biography information for Tom Brake

1017233

	registered interest
	date	29/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Patients: Travel
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, with reference to the finding of CLIC Sargent in their report entitled Are We Nearly There Yet?, published in September 2018, that only six per cent of parents have received help from the Healthcare Travel Costs Scheme, what steps his Department is taking to ensure all families on low incomes have access to financial support to manage healthcare-related travel costs.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Tom Brake
	uin	197311
	answer	answer is ministerial correction date of answer 07/12/2018 answer text <p>The Healthcare Travel Costs Scheme is set up to assist those on low income or in receipt of certain qualifying benefits to obtain assistance with travel to hospitals.</p><p> </p><p>Information on how to obtain assistance with travel costs is widely available from National Health Service organisations including general practitioner surgeries, hospitals, clinical commissioning groups and the NHS website. Outside of the NHS, information may also be obtained from Healthwatch, Citizen Advice, cancer and other charities.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/12/2018 13:01:21 answering member 4067 label Biography information for Steve Brine
	tabling member	151 label Biography information for Tom Brake

1017234

	registered interest
	date	29/11/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Out of Area Treatment: Northern Ireland
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans the Government has to facilitate cross-border arrangements to allow for sufferers of medical illnesses in Northern Ireland to easily enter the Republic of Ireland in order to have treatment administered in specialist centres in that country in the event of the UK leaving the EU (a) with and (b) without a deal.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Tom Brake
	uin	197312
	answer	answer is ministerial correction date of answer 04/12/2018 answer text <p>The agreement we have reached with the European Union is that during the implementation period all reciprocal healthcare rights will continue and there will be no changes to healthcare for pensioners, workers, students, tourists and other visitors, the European Health Insurance Card scheme, or planned treatment. The Healthcare (International Arrangements) Bill will then allow us to implement a deal regarding our future healthcare relationship with the EU, including the Republic of Ireland.</p><p> </p><p>A deal remains in the best interests of the United Kingdom. However, as a responsible Government we are planning for all outcomes.</p><p> </p><p>In the event of a no-deal, the UK would like to enter into reciprocal agreements with individual EU Member States including with Ireland after the UK’s withdrawal from the EU.</p><p> </p><p>We recognise our unique relationship with Ireland and the importance of the Common Travel Area (CTA). The UK and Ireland are both committed to maintaining the current access to health care under the CTA after the UK’s withdrawal from the EU.</p><p> </p><p>Our focus is on securing the right outcome for the whole of the UK, including Northern Ireland.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 04/12/2018 14:42:24 answering member 1585 label Biography information for Stephen Hammond
	tabling member	151 label Biography information for Tom Brake

1020456

	registered interest
	date	05/12/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Health Services: Reciprocal Arrangements
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 4 December 2018 to Question 197312 on Out of Area Treatment: Northern Ireland, what assent has been given to the Government by each EU Member State on entering into reciprocal agreements with individual EU Member States to ensure the maintenance of (a) healthcare for (i) pensioners, (ii) workers, (iii) students, (iv) tourists and (v) other visitors, (b) the European Health Insurance Card scheme and (c) planned treatment.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Tom Brake
	uin	199266
	answer	answer is ministerial correction date of answer 10/12/2018 answer text <p>The agreement we have reached with the European Union is that during the implementation period all reciprocal healthcare rights will continue and there will be no changes to healthcare for pensioners, workers, students, tourists and other visitors, the European Health Insurance Card scheme, or planned treatment. The Healthcare (International Arrangements) Bill will then allow us to implement a deal regarding our future healthcare relationship with the EU.</p><p> </p><p>A deal remains in the best interests of the United Kingdom. However, as a responsible Government we are planning for all outcomes.</p><p> </p><p>Our offer to all Member States is to maintain reciprocal healthcare arrangements bilaterally in a no deal, including for pensioners, workers, students, tourists and other visitors and others along with the current administrative arrangements including reimbursement of healthcare costs, for a transitional period lasting no less than the Implementation Period (i.e. 31 December 2020).</p><p> </p><p>Talks with Ireland on the Common Travel Area are progressing well on ensuring that UK and Irish people can easily obtain healthcare when they live in, work in or visit the UK and Ireland.</p> answering member constituency Wimbledon answering member printed Stephen Hammond question first answered 10/12/2018 16:21:25 answering member 1585 label Biography information for Stephen Hammond
	tabling member	151 label Biography information for Tom Brake

837778

	registered interest
	date	06/02/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Depressive Illnesses
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, when the second consultation on the Nice guidelines for depression in adults will be (a) launched and (b) completed.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Tom Brake
	uin	126809
	answer	answer is ministerial correction date of answer 08/02/2018 answer text <p>The National Institute for Health and Care Excellence (NICE) is currently updating its clinical guideline on the treatment and management of depression in adults. A consultation was held between July and September 2017 and NICE is considering the comments received. NICE is currently working to finalise a launch and completion date.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 08/02/2018 17:01:14 answering member 4067 label Biography information for Steve Brine
	tabling member	151 label Biography information for Tom Brake

846869

	registered interest
	date	22/02/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Postnatal Care
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what information his Department holds on the provision of postnatal check-ups by GP practices.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Tom Brake
	uin	129043
	answer	answer is ministerial correction date of answer 01/03/2018 answer text <p>The Department does not hold data relating to the take up of postnatal check-ups in general practitioner (GP) practices.</p><p> </p><p>The Care Quality Commission’s 2017 survey of women’s experiences of maternity care, found that 92% of the 17,570 respondents said the midwife had told them that they would need to arrange a postnatal check-up of their own health with their GP around six to eight weeks after the birth.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 01/03/2018 15:30:57 answering member 4065 label Biography information for Dame Jackie Doyle-Price
	tabling member	151 label Biography information for Tom Brake

868414

	registered interest
	date	21/03/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	European Food Safety Authority
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether it is his policy for the UK to remain part of the European Food Safety Agency in the event that the UK leaves the EU.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Tom Brake
	uin	133634
	answer	answer is ministerial correction date of answer 28/03/2018 answer text <p>Departments are currently working together to understand the impacts that withdrawal from the European Union will have across a number of sectors and cross-cutting areas, including the European Food Safety Authority. The European Food Safety Authority provides independent scientific advice and risk assessments covering a wide range of policy areas. Options for the future of risk assessment and scientific advice in the United Kingdom are being developed and assessed by the Government. Requirements will depend on the nature of the relationship the UK has with the European Food Safety Authority once the UK leaves the EU. It will be a priority to maintain the UK’s high standards of food and feed safety, and to ensure we take a risk-based, proportionate approach when providing risk assessments.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 28/03/2018 14:39:05 answering member 4067 label Biography information for Steve Brine
	tabling member	151 label Biography information for Tom Brake

882247

	registered interest
	date	13/04/2018
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Motor Neurone Disease
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to his Oral Answer of 20 March 2018, Official Report, column 156, on motor neurone disease, which projects received that £52 million investment; and which 24 clinical trials are being recruited to.
	tabling member constituency	Carshalton and Wallington
	tabling member printed	Tom Brake
	uin	135354
	answer	answer is ministerial correction date of answer 19/04/2018 answer text <p>In 2016-17, the National Institute for Health Research (NIHR) invested £52.2 million into health research covered by the ‘Neurological conditions’ category of the UK Health Research Classification System. This £52.2 million was used to fund and support a range of research studies and research infrastructure for neurological conditions and within that, £4.58 million was spent specifically on Motor Neurone Disease (MND) and closely-related conditions.</p><p> </p><p>The NIHR provides the support, expertise and facilities that the NHS needs to undertake world-leading research funded by the NIHR, and other public, charity and life sciences industry partners, by funding a range of infrastructure facilities.</p><p> </p><p>The NIHR Clinical Research Network is currently supporting 19 non-commercial studies and clinical trials on MND and closely-related conditions which are open and recruiting participants. The non-commercial studies are listed in the table below. There are currently two commercial studies which are also recruiting participants.</p><p> </p><p>In 2016-17, the NIHR Research Infrastructure supported 23 studies and trials on MND and closely-related conditions in the NIHR Biomedical Research Centres, Units and other research infrastructure. The majority of these studies have been funded by research charities including the Motor Neurone Disease Association, other research funders and the life sciences industry.</p><p> </p><p>NIHR Clinical Research Network supported Non-Commercial studies on MND and closely-related conditions which are open and recruiting participants</p><table><tbody><tr><td><p>CPMS Study ID</p></td><td><p>Study Short Name</p></td></tr><tr><td><p>12497</p></td><td><p>Trajectories of Outcome in Neurological Conditions Phase 3 Consent and questionnaire</p></td></tr><tr><td><p>12495</p></td><td><p>Trajectories of Outcome in Neurological Conditions Phase 2 Demographics and Clinical Info</p></td></tr><tr><td><p>12768</p></td><td><p>Motor System Genomics, version 1.0</p></td></tr><tr><td><p>6160</p></td><td><p>ALS Biomarkers Study</p></td></tr><tr><td><p>35238</p></td><td><p>Tonic 2 Phase 4</p></td></tr><tr><td><p>20690</p></td><td><p>MND Register for England, Wales and Northern Ireland</p></td></tr><tr><td><p>12118</p></td><td><p>Trajectories of Outcome in Neurological Conditions Phase 1</p></td></tr><tr><td><p>13182</p></td><td><p>CSF collection in patients with neurodegenerative diseases</p></td></tr><tr><td><p>16242</p></td><td><p>BioMOx Phase 2: The Oxford Study for Biomarkers in Motor Neuron Disease</p></td></tr><tr><td><p>31877</p></td><td><p>A Multicentre Biomarker Study in Neurodegeneration</p></td></tr><tr><td><p>20372</p></td><td><p>Contributing clinical MRI scans to multi-centre collaboration</p></td></tr><tr><td><p>19128</p></td><td><p>Tongue EIM</p></td></tr><tr><td><p>17831</p></td><td><p>Using MRI to investigate energy metabolism in MND</p></td></tr><tr><td><p>34909</p></td><td><p>Improving support for family and friends caring for people with MND</p></td></tr><tr><td><p>35042</p></td><td><p>Serial fasciculation measurements in motor neurone disease</p></td></tr><tr><td><p>17557</p></td><td><p>Care Augmentation by Location-linked messaging CALL-Me</p></td></tr><tr><td><p>32678</p></td><td><p>MIROCALS_H2020/PHRC-N/2014/GB-01_ID-IL-2_Neuro-Inflammation in ALS Pts</p></td></tr><tr><td><p>36434</p></td><td><p>Change in MND</p></td></tr><tr><td><p>37175</p></td><td><p>ProSec 3</p></td></tr></tbody></table> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 19/04/2018 14:15:01 answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	151 label Biography information for Tom Brake